Close X
Attorney Spotlight

How did an interest in healthcare policy lead Robert Platt to a career in the law? Find out more>

Search

Close X

Experience

Search our Experience

Experience Spotlight

Envision to Sell to KKR for $9.9 Billion

We represented Envision Healthcare Corporation (NYSE: EVHC) in its definitive agreement to sell to KKR in an all-cash transaction for $9.9 billion, including debt. KKR will pay $46 per Envision share in cash to buy the company, marking a 32 percent premium to the company's volume-weighted average share price from November 1, when Envision announced it was considering its options. The transaction is expected to close the fourth quarter of 2018. Read more


Envision Healthcare

Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Six Things to Know Before Buying a Physician Practice spotlight

Dermatology, ophthalmology, radiology, urology…the list goes on. Yet, in any physician practice management transaction, there are six key considerations that apply and, if not carefully managed, can derail a transaction. Download the 6 Things to Know Before Buying a Physician Practice to keep your physician practice management transactions on track.

Click here to download the guide.

Lindsey Brown Fetzer

Associate

Lindsey Brown Fetzer

Associate

Washington, D.C.
(202) 827-2964 TEL
(202) 595-0238 FAX
Washington, D.C.
(202) 827-2964 TEL
(202) 595-0238 FAX

Lindsey B. Fetzer focuses her practice on white collar and corporate compliance matters, including healthcare fraud and abuse issues. Lindsey has represented clients in foreign and domestic matters involving the U.S. Department of Justice, the U.S. Securities and Exchange Commission, and other primary enforcement agencies.

Lindsey B. Fetzer focuses her practice on white collar and corporate compliance matters, including healthcare fraud and abuse issues. Lindsey has represented clients in foreign and domestic matters involving the U.S. Department of Justice, the U.S. Securities and Exchange Commission, and other primary enforcement agencies.

Lindsey has experience in matters involving the Foreign Corrupt Practices Act (FCPA) and has conducted internal investigations and risk-based anti-corruption compliance reviews in Asia, Africa, Europe and South America. She also assists clients in developing and assessing anti-corruption compliance programs and in evaluating anti-corruption due diligence protocols.

Prior to joining Bass, Berry & Sims, Lindsey was an associate at two international law firms, resident in Washington, D.C., during which time she spent several months seconded to Verizon Communications, Inc. (2010-11) and to Ford Motor Company (2012).

Lindsey earned her J.D., magna cum laude, from Washington and Lee University School of Law. While in law school, she interned at the U.S. Attorney's Office for the Eastern District of Virginia in Alexandria, VA. Lindsey earned her B.A., magna cum laude, in political science and Spanish from Vanderbilt University.

+ Read More

- Read Less

Memberships

American Bar Association

American Health Lawyers Association (AHLA)

Women's White Collar Defense Association

News

View More

Representative Experience

View More

Publications

View More

Past Events

View More

Media Mentions

View More

Accolades

Washington, D.C. Super Lawyers "Rising Star" (2015-2018)

Washington and Lee Journal of Civil Rights and Social Justice — Lead Articles Editor

Notice

Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.